Abstract
The effect of nutrition and dietary supplements on the course of multiple sclerosis is a topic of great interest to both patients and clinicians. The influence of ω-3 polyunsaturated fatty acids (PUFAs) on the development and course of multiple sclerosis (MS) has been under investigation. A number of small, uncontrolled clinical trials with fish oil (rich in eicosapentaenoic acid (EPA; 20:5 ω-3) and docosahexaenoic acid (DHA; 22:6 ω-3) have indicated a possible beneficial effects of ω-3 PUFAs, but controlled trials have not been able to draw definitive conclusions. Among ω-3 PUFAs, EPA has the most potent effect on myelinogenesis and inflammatory process, thus the conflicting results could be due to the different mixtures of EPA and DHA contained in the various sources of fish oil. This review discusses on the possible role of EPA in demyelinating diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
